Silence Therapeutics Cash Flow Statement 2019-2024 | SLN

Fifteen years of historical annual cash flow statements for Silence Therapeutics (SLN).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-62.58$-58.59$-63.06$-46.28$0.00
$0.62$0.60$0.59$0.64$0
$19.79$11.37$12.35$3.97$0
$20.41$11.96$12.93$4.61$0
$0.39$-0.72$37.79$-37.62$0
$0$0$0$0$0
$0.05$1.79$3.31$1.67$0
$-14.95$-10.67$12.32$59.91$0
$-14.51$-9.60$53.42$23.96$0
$-48.95$-56.22$9.36$-13.84$0
$-0.06$-0.17$-1.80$-0.65$0
$0$-0.37$-0.03$0.00$0
$0$0$0$0$0
$19.30$0$0$0$0
$0$-19.95$13.75$12.84$0
$19.30$-19.95$13.75$12.84$0
$1.19$0.03$0.01$0.17$0
$20.44$-20.46$11.93$12.35$0
$0$0$0$0$0
$-0.22$-0.24$-0.29$-0.52$0
$-0.22$-0.24$-0.29$-0.52$0
$31.51$53.48$42.52$20.33$0
$31.51$53.48$42.52$20.33$0
$0$0$0$0$0
$0$0$0$0$0
$31.29$53.25$42.23$19.81$0
$-0.98$-23.16$63.38$17.89$0
$16.23$12.68$11.87$5.64$0
$0$0$0$0$0